Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder. / Thomsen, Birgitte Liang Chen; Herz, Damian Marc; Siebner, Hartwig Roman; Løkkegaard, Annemette.

In: Ugeskrift for Læger, Vol. 179, V06160433, 2017.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Thomsen, BLC, Herz, DM, Siebner, HR & Løkkegaard, A 2017, 'Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder', Ugeskrift for Læger, vol. 179, V06160433. <http://ugeskriftet.dk/videnskab/dyskinesier-ved-parkinsons-sygdom-opdatering-om-nye-billeddannende-metoder-og>

APA

Thomsen, B. L. C., Herz, D. M., Siebner, H. R., & Løkkegaard, A. (2017). Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder. Ugeskrift for Læger, 179, [V06160433]. http://ugeskriftet.dk/videnskab/dyskinesier-ved-parkinsons-sygdom-opdatering-om-nye-billeddannende-metoder-og

Vancouver

Thomsen BLC, Herz DM, Siebner HR, Løkkegaard A. Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder. Ugeskrift for Læger. 2017;179. V06160433.

Author

Thomsen, Birgitte Liang Chen ; Herz, Damian Marc ; Siebner, Hartwig Roman ; Løkkegaard, Annemette. / Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder. In: Ugeskrift for Læger. 2017 ; Vol. 179.

Bibtex

@article{f6abc672c755432993e3a67e6a43ed2e,
title = "Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder",
abstract = "Levodopa-induced dyskinesia (LID) represents a severe adverse effect of long-term treatment of Parkinson's disease with levodopa. Neuroimaging studies have contributed to our understanding of LID and may help to identify patients at risk of developing LID. Amantadine can be used for the treatment of LID, and novel drugs are under development. Deep brain stimulation of the subthalamic nucleus and globus pallidus internus alleviates LID, the former indirectly by reducing levodopa intake, the latter through direct effects. Repetitive transcranial magnetic stimulation has been shown to transiently improve LID.",
author = "Thomsen, {Birgitte Liang Chen} and Herz, {Damian Marc} and Siebner, {Hartwig Roman} and Annemette L{\o}kkegaard",
year = "2017",
language = "Dansk",
volume = "179",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",

}

RIS

TY - JOUR

T1 - Dyskinesier ved Parkinsons sygdom: opdatering om nye billeddannende metoder og behandlingsmuligheder

AU - Thomsen, Birgitte Liang Chen

AU - Herz, Damian Marc

AU - Siebner, Hartwig Roman

AU - Løkkegaard, Annemette

PY - 2017

Y1 - 2017

N2 - Levodopa-induced dyskinesia (LID) represents a severe adverse effect of long-term treatment of Parkinson's disease with levodopa. Neuroimaging studies have contributed to our understanding of LID and may help to identify patients at risk of developing LID. Amantadine can be used for the treatment of LID, and novel drugs are under development. Deep brain stimulation of the subthalamic nucleus and globus pallidus internus alleviates LID, the former indirectly by reducing levodopa intake, the latter through direct effects. Repetitive transcranial magnetic stimulation has been shown to transiently improve LID.

AB - Levodopa-induced dyskinesia (LID) represents a severe adverse effect of long-term treatment of Parkinson's disease with levodopa. Neuroimaging studies have contributed to our understanding of LID and may help to identify patients at risk of developing LID. Amantadine can be used for the treatment of LID, and novel drugs are under development. Deep brain stimulation of the subthalamic nucleus and globus pallidus internus alleviates LID, the former indirectly by reducing levodopa intake, the latter through direct effects. Repetitive transcranial magnetic stimulation has been shown to transiently improve LID.

M3 - Tidsskriftartikel

C2 - 28263159

VL - 179

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V06160433

ER -

ID: 195900288